IQVIA’s white paper urges life sciences companies to evolve from product-focused strategies to becoming partners in healthcare transformation. Using the Map, Model, Act framework, companies can map disease landscapes to identify unmet needs, model strategies balancing system priorities and business goals, and act through partnerships that improve access and outcomes. Case studies in oncology, rare disease, and lung cancer show how this approach boosts diagnosis, accelerates care, and strengthens adoption. Benefits include improved system readiness, better patient outcomes, commercial growth, and stronger trust between industry and healthcare stakeholders.

Join for free to read